References
- Tune L , CarrS, HoagE, CooperT. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am. J. Psychiatry149(10), 1393–1394(1992).
- Chew ML , MulsantBH, PollockBGet al. Anticholinergic activity of 107 medications commonly used by older adults. J. Am.Geriatr. Soc. 56(7), 1333–1341(2008).
- Han L , McCuskerJ, ColeM, AbrahamowiczM, PrimeauF, ElieM. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch. Intern. Med.161(8), 1099–1105(2001).
- Gerretsen P , PollockBG. Drugs with anticholinergic properties: a current perspective on use and safety. Expert Opin. Drug Saf.10(5), 751–765(2011).
- Modi A , WeinerM, CraigBA, SandsLP, RosenmanMB, ThomasJ 3rd. Concomitant use of anticholinergics with acetylcholinesterase inhibitors in Medicaid recipients with dementia and residing in nursing homes. J. Am. Geriatr. Soc.57(7), 1238–1244(2009).
- Mulsant BH , PollockBG, KirshnerM, ShenC, DodgeH, GanguliM. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch. Gen. Psychiatry60(2), 198–203(2003).
- Gerretsen P , PollockBG. Rediscovering adverse anticholinergic effects. J. Clin. Psychiatry72(6), 869–870(2011).
- Raedler TJ , BymasterFP, TandonR, CopolovD, DeanB. Towards a muscarinic hypothesis of schizophrenia. Mol. Psychiatry12(3), 232–246(2007).
- Sarter M , ParikhV. Choline transporters, cholinergic transmission and cognition. Nat. Rev. Neurosci.6(1), 48–56(2005).
- Mesulam MM . The cholinergic innervation of the human cerebral cortex. Prog. Brain Res.145, 67–78(2004).
- Barak S . Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndrome. Behav. Brain Res.204(2), 335–351(2009).
- Canadian Pharmacists Association. Compendium of Pharmaceuticals and Specialties: the Canadian Drug Reference for Health Professionals (2007 Edition). Canadian Pharmacists Association, ON, Canada (2007).
- Abrams P , CardozoL, FallMet al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am. J. Obstet. Gynecol. 187(1), 116–126(2002).
- Milsom I , AbramsP, CardozoL, RobertsRG, ThuroffJ, WeinAJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int.87(9), 760–766(2001).
- Schweitzer P , MarkH. The effect of atropine on cardiac arrhythmias and conduction. Part 2. Am. Heart J.100(2), 255–261(1980).
- Schweitzer P , MarkH. The effect of atropine on cardiac arrhythmias and conduction. Part 1. Am. Heart J.100(1), 119–127(1980).
- Leon C , GerretsenP, UchidaH, SuzukiT, RajjiT, MamoDC. Sensitivity to antipsychotic drugs in older adults. Curr. Psychiatry Rep.12(1), 28–33(2010).
- Schliebs R , ArendtT. The cholinergic system in aging and neuronal degeneration. Behav. Brain Res.221(2), 555–563(2011).
- Brenner SS , KlotzU. P-glycoprotein function in the elderly. Eur. J. Clin. Pharmacol.60(2), 97–102(2004).
- Wong DF , WagnerHN Jr, Dannals RF et al. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science226(4681), 1393–1396(1984).
- Burke SN , BarnesCA. Neural plasticity in the ageing brain. Nat. Rev. Neurosci.7(1), 30–40(2006).
- Bartus RT . On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp. Neurol.163(2), 495–529(2000).
- Bartus RT , DeanRL 3rd, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science217(4558), 408–414(1982).
- Fibiger HC . Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci.14(6), 220–223(1991).
- Mufson EJ , GinsbergSD, IkonomovicMD, DekoskyST. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J. Chem. Neuroanat.26(4), 233–242(2003).
- Whitehouse PJ , PriceDL, StrubleRG, ClarkAW, CoyleJT, DelonMR. Alzheimer‘s disease and senile dementia: loss of neurons in the basal forebrain. Science215(4537), 1237–1239(1982).
- Chew ML , MulsantBH, PollockBG. Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia. Am. J. Geriatr. Psychiatry13(6), 535–538(2005).
- Rovner BW , DavidA, Lucas-BlausteinMJ, ConklinB, FilippL, TuneL. Self-care capacity and anticholinergic drug levels in nursing home patients. Am. J. Psychiatry145(1), 107–109(1988).
- Cancelli I , ValentinisL, MerlinoG, ValenteM, GigliGL. Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer‘s disease. Clin. Pharmacol. Ther.84(1), 63–68(2008).
- Lu CJ , TuneLE. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am. J. Geriatr. Psychiatry11(4), 458–461(2003).
- Nebes R , PollockBG, MulsantBHet al. Low-level serum anticholinergicity as a source of baseline cognitive heterogeneity in geriatric depressed patients. Psychopharmacol. Bulletin 33, 715–720(1997).
- Cancelli I , GigliGL, PianiAet al. Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study. J. Clin. Psychopharmacol. 28(6), 654–659(2008).
- Carriere I , Fourrier-ReglatA, DartiguesJFet al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch. Intern. Med. 169(14), 1317–1324(2009).
- Aizenberg D , SiglerM, WeizmanA, BarakY. Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case–control study. Int. Psychogeriatr.14(3), 307–310(2002).
- Nebes RD , PollockBG, HalliganEM, KirshnerMA, HouckPR. Serum anticholinergic activity and motor performance in elderly persons. J. Gerontol. A Biol. Sci. Med. Sci.62(1), 83–85(2007).
- Nebes RD , PollockBG, HalliganEM, HouckP, SaxtonJA. Cognitive slowing associated with elevated serum anticholinergic activity in older individuals is decreased by caffeine use. Am. J. Geriatr. Psychiatry19(2), 169–175(2010).
- Nebes RD , PollockBG, PereraS, HalliganEM, SaxtonJA. The greater sensitivity of elderly APOE epsilon4 carriers to anticholinergic medications is independent of cerebrovascular disease risk. Am. J. Geriatr. Pharmacother.10(3), 185–192(2012).
- Uusvaara J , PitkalaKH, TienariPJ, KautiainenH, TilvisRS, StrandbergTE. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study. J. Am. Geriatr. Soc.57(3), 427–431(2009).
- Campbell NL , BoustaniMA, LaneKAet al. Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology 75(2), 152–159(2010).
- Mangoni AA , Van Munster BC, Woodman RJ, De Rooij SE. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am. J. Geriatr. Psychiatry doi:10.1097/JGP.0b013e3182546182 (2012) (Epub ahead of print).
- Hilmer SN , MagerDE, SimonsickEMet al. A drug burden index to define the functional burden of medications in older people. Arch. Intern. Med. 167(8), 781–787(2007).
- Carnahan RM , LundBC, PerryPJ, PollockBG, CulpKR. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J. Clin. Pharmacol.46(12), 1481–1486(2006).
- Kersten H , MoldenE, WillumsenT, EngedalK, WyllerTB. Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes. Br. J. Clin. Pharmacol.75(3), 842–849(2012).
- Kersten H , MoldenE, ToloIK, SkovlundE, EngedalK, WyllerTB. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. J. Gerontol. A Biol. Sci. Med. Sci.68(3), 271–278(2012).
- Tune L , CoyleJT. Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch. Gen. Psychiatry37(3), 293–297(1980).
- Vinogradov S , FisherM, WarmH, HollandC, KirshnerMA, PollockBG. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. Am. J. Psychiatry166(9), 1055–1062(2009).
- Nishtala PS , FoisRA, MclachlanAJ, BellJS, KellyPJ, ChenTF. Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people. J. Clin. Pharmacol.49(10), 1176–1184(2009).
- Carnahan RM , LundBC, PerryPJ, PollockBG. A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice. Psychopharmacol. Bull.36(2), 24–39(2002).
- Alzheimer‘s Association. 2012 Alzheimer‘s disease facts and figures. Alzheimers Dement.8(2), 131–168(2012).
- American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc.60(4), 616–631(2012).
Website
- Silvermedia. www.silvermedia.ca